Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Novartis Ag (NVS)

Novartis Ag (NVS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 196,622,224
  • Shares Outstanding, K 2,288,700
  • Annual Sales, $ 49,898 M
  • Annual Income, $ 8,072 M
  • 60-Month Beta 0.56
  • Price/Sales 4.08
  • Price/Cash Flow 10.29
  • Price/Book 3.50
Trade NVS with:

Options Overview

Details
  • Implied Volatility 23.99%
  • Historical Volatility 14.89%
  • IV Percentile 58%
  • IV Rank 7.88%
  • IV High 124.25% on 03/16/20
  • IV Low 15.42% on 10/09/20
  • Put/Call Vol Ratio 1.23
  • Today's Volume 2,206
  • Volume Avg (30-Day) 3,438
  • Put/Call OI Ratio 0.17
  • Today's Open Interest 48,058
  • Open Int (30-Day) 46,240

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate 1.64
  • Number of Estimates 1
  • High Estimate 1.64
  • Low Estimate 1.64
  • Prior Year 1.55
  • Growth Rate Est. (year over year) +5.81%

Price Performance

See More
Period Period Low Period High Performance
1-Month
85.63 +0.33%
on 02/26/21
94.88 -9.45%
on 01/27/21
-10.03 (-10.45%)
since 01/26/21
3-Month
85.63 +0.33%
on 02/26/21
98.52 -12.80%
on 01/25/21
-3.27 (-3.67%)
since 11/25/20
52-Week
69.18 +24.18%
on 03/16/20
98.52 -12.80%
on 01/25/21
-1.20 (-1.38%)
since 02/26/20

Most Recent Stories

More News
Oncology Drugs Global Market Report 2021: COVID 19 Impact and Recovery to 2030

Reportlinker.com announces the release of the report "Oncology Drugs Global Market Report 2021: COVID 19 Impact and Recovery to 2030" - https://www.reportlinker.com/p06027741/?utm_source=GNW

BAYRY : 15.3000 (-2.65%)
GILD : 61.40 (-2.21%)
NVS : 85.91 (-0.92%)
Ophthalmology Drugs Global Market Report 2021: COVID 19 Impact and Recovery to 2030

Reportlinker.com announces the release of the report "Ophthalmology Drugs Global Market Report 2021: COVID 19 Impact and Recovery to 2030" - https://www.reportlinker.com/p06027742/?utm_source=GNW

AGN : 193.02 (+0.02%)
NVS : 85.91 (-0.92%)
Respiratory Diseases Drugs Global Market Report 2021: COVID 19 Implications and Growth to 2030

Reportlinker.com announces the release of the report "Respiratory Diseases Drugs Global Market Report 2021: COVID 19 Implications and Growth to 2030" - https://www.reportlinker.com/p06027743/?utm_source=GNW...

AZN : 48.38 (-1.08%)
MRK : 72.62 (-2.68%)
NVS : 85.91 (-0.92%)
Current research: Ophthalmic Devices Market key players insight & growth driver analysis 2021

The global ophthalmic devices market was valued at $53,428.8 million in 2019, and is projected to reach $66,719.3 million by 2027, registering a CAGR of 4.2% from 2020 to 2027.

CZMWF : 154.2977 (+15.84%)
NVS : 85.91 (-0.92%)
STAA : 104.01 (-2.15%)
VRX.TO : 30.80 (-3.33%)
Intravitreal (IVT) Injectables Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast 2020 to 2027

The Global is poised to register a CAGR of over 4.7% during the forecast period 2020 to 2027.

ALIM : 8.07 (+1.51%)
AGN : 193.02 (+0.02%)
NVS : 85.91 (-0.92%)
REGN : 450.57 (-0.58%)
VRX.TO : 30.80 (-3.33%)
Hydroxychloroquine Market Size to Hit USD 2,339.1 Million and Grow at 5.5% CAGR by 2027; Increasing Demand for the Product Will provide Impetus to Market Growth, says Fortune Business Insights(TM)

The global hydroxychloroquine market size is projected to reach USD 2,339.1 million by the end of 2027. The increasing incidence of COVID-19 infection will bode well for the market in the coming years....

BAYRY : 15.3000 (-2.65%)
NVS : 85.91 (-0.92%)
TEVA : 10.76 (-2.18%)
4 Healthcare Stocks to Buy and Hold for the Long Term

The healthcare sector in the United States is on the cusp of major growth. Factors such as positivity around the COVID-19 vaccine, an ageing U.S. population, and optimism over developments in the treatment...

NVS : 85.91 (-0.92%)
ABT : 119.78 (-1.48%)
MRK : 72.62 (-2.68%)
LLY : 204.89 (+0.52%)
Worldwide Cephalosporin Industry to 2026 - by Generation, Route of Administration, Application and Region

, /PRNewswire/ -- The report has been added to offering.

AGN : 193.02 (+0.02%)
BMY : 61.33 (-1.24%)
GSK : 33.61 (-2.24%)
MRK : 72.62 (-2.68%)
NVS : 85.91 (-0.92%)
PFE : 33.49 (-0.98%)
TEVA : 10.76 (-2.18%)
Eye Care Surgical Market Overall Study Report with Top Key Players , size and Application

Japan, Japan, Wed, 24 Feb 2021 07:40:13 / Comserve Inc. / -- Eye Care Surgical Market :Global Size, Share Report,Market Trends, Industry Forecast, Growth, Trends Analysis, Keyplayers & Regional Analysis...

CZMWF : 154.2977 (+15.84%)
NVS : 85.91 (-0.92%)
VRX.TO : 30.80 (-3.33%)
Ophthalmic Devices Global Market Report 2021: COVID 19 Impact and Recovery to 2030

Reportlinker.com announces the release of the report "Ophthalmic Devices Global Market Report 2021: COVID 19 Impact and Recovery to 2030" - https://www.reportlinker.com/p06027745/?utm_source=GNW

HOCPF : 115.4200 (-2.74%)
NVS : 85.91 (-0.92%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Average short term outlook on maintaining the current direction.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Novartis AG is committed to improving health and well-being through innovative products and services. The company aspires to capture and hold a leadership position in all of their businesses with a strong, sustainable performance based on continuous innovation. Their long-term success is founded on...

See More

Key Turning Points

3rd Resistance Point 88.45
2nd Resistance Point 87.83
1st Resistance Point 86.87
Last Price 85.91
1st Support Level 85.29
2nd Support Level 84.67
3rd Support Level 83.71

See More

52-Week High 98.52
Fibonacci 61.8% 87.31
Last Price 85.91
Fibonacci 50% 83.85
Fibonacci 38.2% 80.39
52-Week Low 69.18

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar